Fulgent Genetics, Inc. FLGT Laboratory Services — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s laboratory services — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s laboratory services — revenue?
- Fulgent Genetics, Inc. (FLGT) reported laboratory services — revenue of $71.05M in Q1 2026.
- How has Fulgent Genetics, Inc.'s laboratory services — revenue changed year-over-year?
- Fulgent Genetics, Inc.'s laboratory services — revenue decreased by 3.3% year-over-year, from $73.46M to $71.05M.
- What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — revenue?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s laboratory services — revenue has grown at a -24.5% compound annual growth rate (CAGR), from $992.58M to $322.22M.
- What does laboratory services — revenue mean?
- This represents the total gross income generated from the provision of laboratory diagnostic and interpretation services, excluding assessed taxes. It is the primary measure of the scale and commercial success of the company's core laboratory operations.